# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-028859
Filing Date
2024-04-01
Accepted
2024-04-01 17:03:54
Documents
110
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | ea0202882-20f_scisparc.htm iXBRL | 20-F | 2618720
2 | DESCRIPTION OF SECURITIES | ea020288201ex2-1_scisparc.htm | EX-2.1 | 62452
3 | CERTIFICATION | ea020288201ex12-1_scisparc.htm | EX-12.1 | 9157
4 | CERTIFICATION | ea020288201ex13-1_scisparc.htm | EX-13.1 | 3293
5 | CONSENT OF KOST FORER GABBAY & KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL, INDEP | ea020288201ex15-1_scisparc.htm | EX-15.1 | 2761
6 | CLAWBACK POLICY | ea020288201ex97-1_scisparc.htm | EX-97.1 | 32745
7 | GRAPHIC | image_001.jpg | GRAPHIC | 1811
| Complete submission text file | 0001213900-24-028859.txt |  | 9269508

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL SCHEMA FILE | sprcy-20231231.xsd | EX-101.SCH | 135756
9 | XBRL CALCULATION FILE | sprcy-20231231_cal.xml | EX-101.CAL | 44583
10 | XBRL DEFINITION FILE | sprcy-20231231_def.xml | EX-101.DEF | 344491
11 | XBRL LABEL FILE | sprcy-20231231_lab.xml | EX-101.LAB | 776463
12 | XBRL PRESENTATION FILE | sprcy-20231231_pre.xml | EX-101.PRE | 367785
114 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0202882-20f_scisparc_htm.xml | XML | 1223789

Mailing Address 20 RAUL WALLENBERG STREET, TOWER A TEL AVIV L3 6971916
Business Address 20 RAUL WALLENBERG STREET, TOWER A TEL AVIV L3 6971916 972-3-6103100
SciSparc Ltd. (Filer) CIK: 0001611746 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38041 | Film No.: 24810684
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)